ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ENDV Endonovo Therapeutics Inc (PK)

0.0015
-0.001 (-40.00%)
10 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2022 201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 083k310k166k73k135k
Operating Income -4.6M-4.16M-3.81M-2.91M-2.23M-3.27M
Pre Tax Income -10.81M-6.44M-17.32M-396k-3.11M-18.48M
Net Income -10.81M-6.44M-17.32M-396k-3.11M-18.48M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.034-0.015-14.563-0.023-0.042-0.095
EBIT -2.04M-3.84M-3.74M-3.36M-2.23M-3.49M
EBITDA -4.59M-3.51M-3.16M-2.26M-1.58M-2.62M

Your Recent History

Delayed Upgrade Clock